Effectiveness of Four Popular Diet Strategies for Weight Loss and Cardiac Risk Reduction
NCT ID: NCT02454127
Last Updated: 2016-10-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2000-07-31
2004-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design, Setting, and Participants: A single-center randomized trial at an academic medical center in Boston, Mass, of overweight or obese adults with known hypertension, dyslipidemia, or fasting hyperglycemia. Participants were enrolled starting July 18, 2000, and randomized to 4 popular diet groups until January 24, 2002.
Intervention: A total of 160 participants were randomly assigned to either Atkins (carbohydrate restriction, n=40), Zone (macronutrient balance, n=40), Weight Watchers (calorie restriction, n=40), or Ornish (fat restriction, n=40) diet groups. After 2 months of maximum effort, participants selected their own levels of dietary adherence.
Main Outcome Measures: One-year changes in baseline weight and cardiac risk factors, and self-selected dietary adherence rates per self-report. Outcome measures included body weight, total cholesterol, LDL-C, HDL-C, triglycerides, hsCRP, insulin, glucose.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atkins Diet
Atkins Diet (dietary counseling)
Atkins Diet
Dietary counseling for 1 year
Zone Diet
Zone Diet (dietary counseling)
Zone Diet
Dietary counseling for 1 year
Weight Watchers Diet
Weight Watchers Diet (dietary counseling)
Weight Watchers Diet
Dietary counseling for 1 year
Ornish Diet
Ornish Diet (dietary counseling)
Ornish Diet
Dietary counseling for 1 year
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atkins Diet
Dietary counseling for 1 year
Zone Diet
Dietary counseling for 1 year
Weight Watchers Diet
Dietary counseling for 1 year
Ornish Diet
Dietary counseling for 1 year
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one metabolic cardiac risk factor
Exclusion Criteria
* Insulin therapy;
* Unstable chronic illness;
* Unwilling to follow dietary advice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael L Dansinger, MD
Role: PRINCIPAL_INVESTIGATOR
Tufts Medical Center
References
Explore related publications, articles, or registry entries linked to this study.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005 Jan 5;293(1):43-53. doi: 10.1001/jama.293.1.43.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DANS0001
Identifier Type: -
Identifier Source: org_study_id